Global Dyspepsia Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Dyspepsia Market Size, by Market Value (USD Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Dyspepsia Market Analysis and Forecast
6.1. Dyspepsia Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Dyspepsia Market Analysis and Forecast, By End-User
7.1. Introduction and Definition
7.2. Key Findings
7.3. Dyspepsia Market Value Share Analysis, By End-User
7.4. Dyspepsia Market Size (USD Bn) Forecast, By End-User
7.5. Dyspepsia Market Analysis, By End-User
7.6. Dyspepsia Market Attractiveness Analysis, By End-User
8. Global Dyspepsia Market Analysis and Forecast, By Treatment
8.1. Introduction and Definition
8.2. Key Findings
8.3. Dyspepsia Market Value Share Analysis, By Treatment
8.4. Dyspepsia Market Size (US$ Bn) Forecast, By Treatment
8.5. Dyspepsia Market Analysis, By Treatment
8.6. Dyspepsia Market Attractiveness Analysis, By Treatment
9. Global Dyspepsia Market Analysis and Forecast, By Diagnosis
9.1. Introduction and Definition
9.2. Key Findings
9.3. Dyspepsia Market Value Share Analysis, By Diagnosis
9.4. Dyspepsia Market Size (US$ Bn) Forecast, By Diagnosis
9.5. Dyspepsia Market Analysis, By Diagnosis
9.6. Dyspepsia Market Attractiveness Analysis, By Diagnosis
10. Global Dyspepsia Market Analysis, by Region
10.1. Dyspepsia Market Value Share Analysis, by Region
10.2. Dyspepsia Market Size (US$ Bn) Forecast, by Region
10.3. Dyspepsia Market Attractiveness Analysis, by Region
11. North America Dyspepsia Market Analysis
11.1. Key Findings
11.2. North America Dyspepsia Market Overview
11.3. North America Dyspepsia Market Value Share Analysis, By End-User
11.4. North America Dyspepsia Market Forecast, By End-User
11.4.1. Hospitals and clinics
11.4.2. Ambulatory surgical centers
11.4.3. Pharmacies
11.4.4. Diagnostic centers
11.4.5. Others
11.5. North America Dyspepsia Market Value Share Analysis, By Treatment
11.6. North America Dyspepsia Market Forecast, By Treatment
11.6.1. Antacids
11.6.2. Antibiotics
11.6.3. H2 Blockers
11.6.4. Proton Pump Inhibitors (PPIs)
11.6.5. Prokinetics
11.6.6. Psychological Therapies
11.6.7. Others
11.7. North America Dyspepsia Market Value Share Analysis, By Diagnosis
11.8. North America Dyspepsia Market Forecast, By Diagnosis
11.8.1. Blood Tests
11.8.2. Breath Tests
11.8.3. Stool Tests
11.8.4. Endoscopy
11.8.5. X-ray
11.8.6. CT scan
11.8.7. Others
11.9. North America Dyspepsia Market Value Share Analysis, by Country
11.10. North America Dyspepsia Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Dyspepsia Market Analysis, by Country
11.12. U.S. Dyspepsia Market Forecast, By End-User
11.12.1. Hospitals and clinics
11.12.2. Ambulatory surgical centers
11.12.3. Pharmacies
11.12.4. Diagnostic centers
11.12.5. Others
11.13. U.S. Dyspepsia Market Forecast, By Treatment
11.13.1. Antacids
11.13.2. Antibiotics
11.13.3. H2 Blockers
11.13.4. Proton Pump Inhibitors (PPIs)
11.13.5. Prokinetics
11.13.6. Psychological Therapies
11.13.7. Others
11.14. U.S. Dyspepsia Market Forecast, By Diagnosis
11.14.1. Blood Tests
11.14.2. Breath Tests
11.14.3. Stool Tests
11.14.4. Endoscopy
11.14.5. X-ray
11.14.6. CT scan
11.14.7. Others
11.15. Canada Dyspepsia Market Forecast, By End-User
11.15.1. Hospitals and clinics
11.15.2. Ambulatory surgical centers
11.15.3. Pharmacies
11.15.4. Diagnostic centers
11.15.5. Others
11.16. Canada Dyspepsia Market Forecast, By Treatment
11.16.1. Antacids
11.16.2. Antibiotics
11.16.3. H2 Blockers
11.16.4. Proton Pump Inhibitors (PPIs)
11.16.5. Prokinetics
11.16.6. Psychological Therapies
11.16.7. Others
11.17. Canada Dyspepsia Market Forecast, By Diagnosis
11.17.1. Blood Tests
11.17.2. Breath Tests
11.17.3. Stool Tests
11.17.4. Endoscopy
11.17.5. X-ray
11.17.6. CT scan
11.17.7. Others
11.18. North America Dyspepsia Market Attractiveness Analysis
11.18.1. By End-User
11.18.2. By Treatment
11.18.3. By Diagnosis
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments
12. Europe Dyspepsia Market Analysis
12.1. Key Findings
12.2. Europe Dyspepsia Market Overview
12.3. Europe Dyspepsia Market Value Share Analysis, By End-User
12.4. Europe Dyspepsia Market Forecast, By End-User
12.4.1. Hospitals and clinics
12.4.2. Ambulatory surgical centers
12.4.3. Pharmacies
12.4.4. Diagnostic centers
12.4.5. Others
12.5. Europe Dyspepsia Market Value Share Analysis, By Treatment
12.6. Europe Dyspepsia Market Forecast, By Treatment
12.6.1. Antacids
12.6.2. Antibiotics
12.6.3. H2 Blockers
12.6.4. Proton Pump Inhibitors (PPIs)
12.6.5. Prokinetics
12.6.6. Psychological Therapies
12.6.7. Others
12.7. Europe Dyspepsia Market Value Share Analysis, By Diagnosis
12.8. Europe Dyspepsia Market Forecast, By Diagnosis
12.8.1. Blood Tests
12.8.2. Breath Tests
12.8.3. Stool Tests
12.8.4. Endoscopy
12.8.5. X-ray
12.8.6. CT scan
12.8.7. Others
12.9. Europe Dyspepsia Market Value Share Analysis, by Country
12.10. Europe Dyspepsia Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Dyspepsia Market Analysis, by Country
12.12. Germany Dyspepsia Market Forecast, By End-User
12.12.1. Hospitals and clinics
12.12.2. Ambulatory surgical centers
12.12.3. Pharmacies
12.12.4. Diagnostic centers
12.12.5. Others
12.13. Germany Dyspepsia Market Forecast, By Treatment
12.13.1. Antacids
12.13.2. Antibiotics
12.13.3. H2 Blockers
12.13.4. Proton Pump Inhibitors (PPIs)
12.13.5. Prokinetics
12.13.6. Psychological Therapies
12.13.7. Others
12.14. Germany Dyspepsia Market Forecast, By Diagnosis
12.14.1. Blood Tests
12.14.2. Breath Tests
12.14.3. Stool Tests
12.14.4. Endoscopy
12.14.5. X-ray
12.14.6. CT scan
12.14.7. Others
12.15. U.K. Dyspepsia Market Forecast, By End-User
12.15.1. Hospitals and clinics
12.15.2. Ambulatory surgical centers
12.15.3. Pharmacies
12.15.4. Diagnostic centers
12.15.5. Others
12.16. U.K. Dyspepsia Market Forecast, By Treatment
12.16.1. Antacids
12.16.2. Antibiotics
12.16.3. H2 Blockers
12.16.4. Proton Pump Inhibitors (PPIs)
12.16.5. Prokinetics
12.16.6. Psychological Therapies
12.16.7. Others
12.17. U.K. Dyspepsia Market Forecast, By Diagnosis
12.17.1. Blood Tests
12.17.2. Breath Tests
12.17.3. Stool Tests
12.17.4. Endoscopy
12.17.5. X-ray
12.17.6. CT scan
12.17.7. Others
12.18. France Dyspepsia Market Forecast, By End-User
12.18.1. Hospitals and clinics
12.18.2. Ambulatory surgical centers
12.18.3. Pharmacies
12.18.4. Diagnostic centers
12.18.5. Others
12.19. France Dyspepsia Market Forecast, By Treatment
12.19.1. Antacids
12.19.2. Antibiotics
12.19.3. H2 Blockers
12.19.4. Proton Pump Inhibitors (PPIs)
12.19.5. Prokinetics
12.19.6. Psychological Therapies
12.19.7. Others
12.20. France Dyspepsia Market Forecast, By Diagnosis
12.20.1. Blood Tests
12.20.2. Breath Tests
12.20.3. Stool Tests
12.20.4. Endoscopy
12.20.5. X-ray
12.20.6. CT scan
12.20.7. Others
12.21. Italy Dyspepsia Market Forecast, By End-User
12.21.1. Hospitals and clinics
12.21.2. Ambulatory surgical centers
12.21.3. Pharmacies
12.21.4. Diagnostic centers
12.21.5. Others
12.22. Italy Dyspepsia Market Forecast, By Treatment
12.22.1. Antacids
12.22.2. Antibiotics
12.22.3. H2 Blockers
12.22.4. Proton Pump Inhibitors (PPIs)
12.22.5. Prokinetics
12.22.6. Psychological Therapies
12.22.7. Others
12.23. Italy Dyspepsia Market Forecast, By Diagnosis
12.23.1. Blood Tests
12.23.2. Breath Tests
12.23.3. Stool Tests
12.23.4. Endoscopy
12.23.5. X-ray
12.23.6. CT scan
12.23.7. Others
12.24. Spain Dyspepsia Market Forecast, By End-User
12.24.1. Hospitals and clinics
12.24.2. Ambulatory surgical centers
12.24.3. Pharmacies
12.24.4. Diagnostic centers
12.24.5. Others
12.25. Spain Dyspepsia Market Forecast, By Treatment
12.25.1. Antacids
12.25.2. Antibiotics
12.25.3. H2 Blockers
12.25.4. Proton Pump Inhibitors (PPIs)
12.25.5. Prokinetics
12.25.6. Psychological Therapies
12.25.7. Others
12.26. Spain Dyspepsia Market Forecast, By Diagnosis
12.26.1. Blood Tests
12.26.2. Breath Tests
12.26.3. Stool Tests
12.26.4. Endoscopy
12.26.5. X-ray
12.26.6. CT scan
12.26.7. Others
12.27. Rest of Europe Dyspepsia Market Forecast, By End-User
12.27.1. Hospitals and clinics
12.27.2. Ambulatory surgical centers
12.27.3. Pharmacies
12.27.4. Diagnostic centers
12.27.5. Others
12.28. Rest of Europe Dyspepsia Market Forecast, By Treatment
12.28.1. Antacids
12.28.2. Antibiotics
12.28.3. H2 Blockers
12.28.4. Proton Pump Inhibitors (PPIs)
12.28.5. Prokinetics
12.28.6. Psychological Therapies
12.28.7. Others
12.29. Rest Of Europe Dyspepsia Market Forecast, By Diagnosis
12.29.1. Blood Tests
12.29.2. Breath Tests
12.29.3. Stool Tests
12.29.4. Endoscopy
12.29.5. X-ray
12.29.6. CT scan
12.29.7. Others
12.30. Europe Dyspepsia Market Attractiveness Analysis
12.30.1. By End-User
12.30.2. By Treatment
12.30.3. By Diagnosis
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments
13. Asia Pacific Dyspepsia Market Analysis
13.1. Key Findings
13.2. Asia Pacific Dyspepsia Market Overview
13.3. Asia Pacific Dyspepsia Market Value Share Analysis, By End-User
13.4. Asia Pacific Dyspepsia Market Forecast, By End-User
13.4.1. Hospitals and clinics
13.4.2. Ambulatory surgical centers
13.4.3. Pharmacies
13.4.4. Diagnostic centers
13.4.5. Others
13.5. Asia Pacific Dyspepsia Market Value Share Analysis, By Treatment
13.6. Asia Pacific Dyspepsia Market Forecast, By Treatment
13.6.1. Antacids
13.6.2. Antibiotics
13.6.3. H2 Blockers
13.6.4. Proton Pump Inhibitors (PPIs)
13.6.5. Prokinetics
13.6.6. Psychological Therapies
13.6.7. Others
13.7. Asia Pacific Dyspepsia Market Value Share Analysis, By Diagnosis
13.8. Asia Pacific Dyspepsia Market Forecast, By Diagnosis
13.8.1. Blood Tests
13.8.2. Breath Tests
13.8.3. Stool Tests
13.8.4. Endoscopy
13.8.5. X-ray
13.8.6. CT scan
13.8.7. Others
13.9. Asia Pacific Dyspepsia Market Value Share Analysis, by Country
13.10. Asia Pacific Dyspepsia Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Dyspepsia Market Analysis, by Country
13.12. China Dyspepsia Market Forecast, By End-User
13.12.1. Hospitals and clinics
13.12.2. Ambulatory surgical centers
13.12.3. Pharmacies
13.12.4. Diagnostic centers
13.12.5. Others
13.13. China Dyspepsia Market Forecast, By Treatment
13.13.1. Antacids
13.13.2. Antibiotics
13.13.3. H2 Blockers
13.13.4. Proton Pump Inhibitors (PPIs)
13.13.5. Prokinetics
13.13.6. Psychological Therapies
13.13.7. Others
13.14. China Dyspepsia Market Forecast, By Diagnosis
13.14.1. Blood Tests
13.14.2. Breath Tests
13.14.3. Stool Tests
13.14.4. Endoscopy
13.14.5. X-ray
13.14.6. CT scan
13.14.7. Others
13.15. India Dyspepsia Market Forecast, By End-User
13.15.1. Hospitals and clinics
13.15.2. Ambulatory surgical centers
13.15.3. Pharmacies
13.15.4. Diagnostic centers
13.15.5. Others
13.16. India Dyspepsia Market Forecast, By Treatment
13.16.1. Antacids
13.16.2. Antibiotics
13.16.3. H2 Blockers
13.16.4. Proton Pump Inhibitors (PPIs)
13.16.5. Prokinetics
13.16.6. Psychological Therapies
13.16.7. Others
13.17. India Dyspepsia Market Forecast, By Diagnosis
13.17.1. Blood Tests
13.17.2. Breath Tests
13.17.3. Stool Tests
13.17.4. Endoscopy
13.17.5. X-ray
13.17.6. CT scan
13.17.7. Others
13.18. Japan Dyspepsia Market Forecast, By End-User
13.18.1. Hospitals and clinics
13.18.2. Ambulatory surgical centers
13.18.3. Pharmacies
13.18.4. Diagnostic centers
13.19. Others Japan Dyspepsia Market Forecast, By Treatment
13.19.1. Antacids
13.19.2. Antibiotics
13.19.3. H2 Blockers
13.19.4. Proton Pump Inhibitors (PPIs)
13.19.5. Prokinetics
13.19.6. Psychological Therapies
13.19.7. Others
13.20. Japan Dyspepsia Market Forecast, By Diagnosis
13.20.1. Blood Tests
13.20.2. Breath Tests
13.20.3. Stool Tests
13.20.4. Endoscopy
13.20.5. X-ray
13.20.6. CT scan
13.20.7. Others
13.21. ASEAN Dyspepsia Market Forecast, By End-User
13.21.1. Hospitals and clinics
13.21.2. Ambulatory surgical centers
13.21.3. Pharmacies
13.21.4. Diagnostic centers
13.21.5. Others
13.22. ASEAN Dyspepsia Market Forecast, By Treatment
13.22.1. Antacids
13.22.2. Antibiotics
13.22.3. H2 Blockers
13.22.4. Proton Pump Inhibitors (PPIs)
13.22.5. Prokinetics
13.22.6. Psychological Therapies
13.22.7. Others
13.23. ASEAN Dyspepsia Market Forecast, By Diagnosis
13.23.1. Blood Tests
13.23.2. Breath Tests
13.23.3. Stool Tests
13.23.4. Endoscopy
13.23.5. X-ray
13.23.6. CT scan
13.23.7. Others
13.24. Rest of Asia Pacific Dyspepsia Market Forecast, By End-User
13.24.1. Hospitals and clinics
13.24.2. Ambulatory surgical centers
13.24.3. Pharmacies
13.24.4. Diagnostic centers
13.24.5. Others
13.25. Others Rest of Asia Pacific Dyspepsia Market Forecast, By Treatment
13.25.1. Antacids
13.25.2. Antibiotics
13.25.3. H2 Blockers
13.25.4. Proton Pump Inhibitors (PPIs)
13.25.5. Prokinetics
13.25.6. Psychological Therapies
13.25.7. Others
13.26. Rest of Asia Pacific Dyspepsia Market Forecast, By Diagnosis
13.26.1. Blood Tests
13.26.2. Breath Tests
13.26.3. Stool Tests
13.26.4. Endoscopy
13.26.5. X-ray
13.26.6. CT scan
13.26.7. Others
13.27. Asia Pacific Dyspepsia Market Attractiveness Analysis
13.27.1. By End-User
13.27.2. By Treatment
13.27.3. By Diagnosis
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments
14. Middle East & Africa Dyspepsia Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Dyspepsia Market Overview
14.3. Middle East & Africa Dyspepsia Market Value Share Analysis, By End-User
14.4. Middle East & Africa Dyspepsia Market Forecast, By End-User
14.4.1. Hospitals and clinics
14.4.2. Ambulatory surgical centers
14.4.3. Pharmacies
14.4.4. Diagnostic centers
14.4.5. Others
14.5. Middle East & Africa Dyspepsia Market Value Share Analysis, By Treatment
14.6. Middle East & Africa Dyspepsia Market Forecast, By Treatment
14.6.1. Antacids
14.6.2. Antibiotics
14.6.3. H2 Blockers
14.6.4. Proton Pump Inhibitors (PPIs)
14.6.5. Prokinetics
14.6.6. Psychological Therapies
14.6.7. Others
14.7. Middle East & Africa Dyspepsia Market Value Share Analysis, By Diagnosis
14.8. Middle East & Africa Dyspepsia Market Forecast, By Diagnosis
14.8.1. Blood Tests
14.8.2. Breath Tests
14.8.3. Stool Tests
14.8.4. Endoscopy
14.8.5. X-ray
14.8.6. CT scan
14.8.7. Others
14.9. Middle East & Africa Dyspepsia Market Value Share Analysis, by Country
14.10. Middle East & Africa Dyspepsia Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Dyspepsia Market Analysis, by Country
14.12. GCC Dyspepsia Market Forecast, By End-User
14.12.1. Hospitals and clinics
14.12.2. Ambulatory surgical centers
14.12.3. Pharmacies
14.12.4. Diagnostic centers
14.12.5. Others
14.13. GCC Dyspepsia Market Forecast, By Treatment
14.13.1. Antacids
14.13.2. Antibiotics
14.13.3. H2 Blockers
14.13.4. Proton Pump Inhibitors (PPIs)
14.13.5. Prokinetics
14.13.6. Psychological Therapies
14.13.7. Others
14.14. GCC Dyspepsia Market Forecast, By Diagnosis
14.14.1. Blood Tests
14.14.2. Breath Tests
14.14.3. Stool Tests
14.14.4. Endoscopy
14.14.5. X-ray
14.14.6. CT scan
14.14.7. Others
14.15. South Africa Dyspepsia Market Forecast, By End-User
14.15.1. Hospitals and clinics
14.15.2. Ambulatory surgical centers
14.15.3. Pharmacies
14.15.4. Diagnostic centers
14.15.5. Others
14.16. South Africa Dyspepsia Market Forecast, By Treatment
14.16.1. Antacids
14.16.2. Antibiotics
14.16.3. H2 Blockers
14.16.4. Proton Pump Inhibitors (PPIs)
14.16.5. Prokinetics
14.16.6. Psychological Therapies
14.16.7. Others
14.17. South Africa Dyspepsia Market Forecast, By Diagnosis
14.17.1. Blood Tests
14.17.2. Breath Tests
14.17.3. Stool Tests
14.17.4. Endoscopy
14.17.5. X-ray
14.17.6. CT scan
14.17.7. Others
14.18. Rest of Middle East & Africa Dyspepsia Market Forecast, By End-User
14.18.1. Hospitals and clinics
14.18.2. Ambulatory surgical centers
14.18.3. Pharmacies
14.18.4. Diagnostic centers
14.18.5. Others
14.19. Rest of Middle East & Africa Dyspepsia Market Forecast, By Treatment
14.19.1. Antacids
14.19.2. Antibiotics
14.19.3. H2 Blockers
14.19.4. Proton Pump Inhibitors (PPIs)
14.19.5. Prokinetics
14.19.6. Psychological Therapies
14.19.7. Others
14.20. Middle East & Africa Dyspepsia Market Forecast, By Diagnosis
14.20.1. Blood Tests
14.20.2. Breath Tests
14.20.3. Stool Tests
14.20.4. Endoscopy
14.20.5. X-ray
14.20.6. CT scan
14.20.7. Others
14.21. Middle East & Africa Dyspepsia Market Attractiveness Analysis
14.21.1. By End-User
14.21.2. By Treatment
14.21.3. By Diagnosis
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments
15. South America Dyspepsia Market Analysis
15.1. Key Findings
15.2. South America Dyspepsia Market Overview
15.3. South America Dyspepsia Market Value Share Analysis, By End-User
15.4. South America Dyspepsia Market Forecast, By End-User
15.4.1. Hospitals and clinics
15.4.2. Ambulatory surgical centers
15.4.3. Pharmacies
15.4.4. Diagnostic centers
15.4.5. Others
15.5. South America Dyspepsia Market Value Share Analysis, By Treatment
15.6. South America Dyspepsia Market Forecast, By Treatment
15.6.1. Antacids
15.6.2. Antibiotics
15.6.3. H2 Blockers
15.6.4. Proton Pump Inhibitors (PPIs)
15.6.5. Prokinetics
15.6.6. Psychological Therapies
15.6.7. Others
15.7. South America Dyspepsia Market Value Share Analysis, By Diagnosis
15.8. South America Dyspepsia Market Forecast, By Diagnosis
15.8.1. Blood Tests
15.8.2. Breath Tests
15.8.3. Stool Tests
15.8.4. Endoscopy
15.8.5. X-ray
15.8.6. CT scan
15.8.7. Others
15.9. South America Dyspepsia Market Value Share Analysis, by Country
15.10. South America Dyspepsia Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Dyspepsia Market Analysis, by Country
15.12. Brazil Dyspepsia Market Forecast, By End-User
15.12.1. Hospitals and clinics
15.12.2. Ambulatory surgical centers
15.12.3. Pharmacies
15.12.4. Diagnostic centers
15.12.5. Others
15.13. Brazil Dyspepsia Market Forecast, By Treatment
15.13.1. Antacids
15.13.2. Antibiotics
15.13.3. H2 Blockers
15.13.4. Proton Pump Inhibitors (PPIs)
15.13.5. Prokinetics
15.13.6. Psychological Therapies
15.13.7. Others
15.14. Brazil Dyspepsia Market Forecast, By Diagnosis
15.14.1. Blood Tests
15.14.2. Breath Tests
15.14.3. Stool Tests
15.14.4. Endoscopy
15.14.5. X-ray
15.14.6. CT scan
15.14.7. Others
15.15. Mexico Dyspepsia Market Forecast, By End-User
15.15.1. Hospitals and clinics
15.15.2. Ambulatory surgical centers
15.15.3. Pharmacies
15.15.4. Diagnostic centers
15.15.5. Others
15.16. Mexico Dyspepsia Market Forecast, By Treatment
15.16.1. Antacids
15.16.2. Antibiotics
15.16.3. H2 Blockers
15.16.4. Proton Pump Inhibitors (PPIs)
15.16.5. Prokinetics
15.16.6. Psychological Therapies
15.16.7. Others
15.17. Mexico Dyspepsia Market Forecast, By Diagnosis
15.17.1. Blood Tests
15.17.2. Breath Tests
15.17.3. Stool Tests
15.17.4. Endoscopy
15.17.5. X-ray
15.17.6. CT scan
15.17.7. Others
15.18. Rest of South America Dyspepsia Market Forecast, By End-User
15.18.1. Hospitals and clinics
15.18.2. Ambulatory surgical centers
15.18.3. Pharmacies
15.18.4. Diagnostic centers
15.18.5. Others
15.19. Rest of South America Dyspepsia Market Forecast, By Treatment
15.19.1. Antacids
15.19.2. Antibiotics
15.19.3. H2 Blockers
15.19.4. Proton Pump Inhibitors (PPIs)
15.19.5. Prokinetics
15.19.6. Psychological Therapies
15.19.7. Others
15.20. Rest of South America Dyspepsia Market Forecast, By Diagnosis
15.20.1. Blood Tests
15.20.2. Breath Tests
15.20.3. Stool Tests
15.20.4. Endoscopy
15.20.5. X-ray
15.20.6. CT scan
15.20.7. Others
15.21. South America Dyspepsia Market Attractiveness Analysis
15.21.1. By End-User
15.21.2. By Treatment
15.21.3. By Diagnosis
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments
16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. AstraZeneca
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. GlaxoSmithKline
16.3.3. Takeda Pharmaceutical Company
16.3.4. Johnson & Johnson
16.3.5. Jiangsu Aosaikang Pharma
16.3.6. Eisai Co., Ltd.
16.3.7. Abbott Laboratories
16.3.8. Salix Pharmaceuticals
16.3.9. Bayer AG
16.3.10. Boehringer Ingelheim GmbH
16.3.11. Sanofi
16.3.12. Allergan Plc
16.3.13. Cadila Pharmaceuticals
16.3.14. Pfizer
16.3.15. Biogen
16.3.16. Astellas Pharma Inc.
16.3.17. ZERIA Pharmaceutical Co., Ltd
16.3.18. DONG - A ST
16.3.19. Beactica AB
16.3.20. Xian Janssen Pharmaceutical Ltd
16.3.21. Novartis AG
16.3.22. YUHAN
16.3.23. Abide Therapeutics, Inc.
17. Primary Key Insights
To know about the Research Methodology:- Request Free Sample Report